Form 4: Medifast CFO James P. Maloney Receives Stock Grant

James P. Maloney, CFO of Medifast, Inc., reports the acquisition of 24,161 shares of common stock through a restricted stock unit grant.

Summary

• On March 25, 2025, James P. Maloney, the Chief Financial Officer of Medifast, Inc., acquired 24,161 shares of common stock.
• This acquisition was a grant of restricted stock units under the 2012 Share Incentive Plan.
• The restricted stock units will vest in three equal annual installments starting on the first anniversary of the grant date.
• Each restricted stock unit represents the right to receive one share of Medifast's common stock.
• Following the transaction, Maloney beneficially owns 42,299 shares of Medifast common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests.

Positives

• The grant of restricted stock units aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date, incentivizing long-term performance.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the stock grant positively as it incentivizes the CFO to improve company performance.
• Employees may see the grant as a sign of the company's commitment to its leadership.

Key Dates

Keywords

Medifast, James P. Maloney, CFO, restricted stock units, stock grant, beneficial ownership, Form 4, MEDI